Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
24 pending office actions • 17 clients • 23 examiners • 16 art units • 0 of 24 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (4%) |
| §103 only | 7 (29%) |
| §102 only | 1 (4%) |
| §112 only | 1 (4%) |
| Double-patenting + other | 3 (12%) |
| Multi-statute (no §101) | 11 (46%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RAMOS LEWIS, JOSMALEN MILAGROS | 2 | 53.6% | +23.9% |
| ALBERS, KEVIN S | 1 | 26.6% | +49.7% |
| BECKHARDT, LYNDSEY MARIE | 1 | 27.8% | +48.0% |
| GATES, BRADFORD M | 1 | 74.8% | +23.8% |
| HINES, LATOSHA D | 1 | 51.2% | +21.7% |
| BRADLEY, CHRISTINA | 1 | 62.6% | +33.3% |
| CHI, AMANDA LYNN | 1 | — | — |
| HUEBNER, ERICA MICHELLE | 1 | 31.7% | +35.5% |
| AZPURU, CARLOS A | 1 | 83.8% | +10.7% |
| SAWYER, STEVEN T | 1 | 72.5% | +30.5% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18753210 | ORAL QUETIAPINE SUSPENSION FORMULATIONS WITH EXTENDED SHELF LIFE AND ENHANCED BIOAVAILABILITY | AZPURU, CARLOS A | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18508992 | TRAZODONE ORAL SOLUTION | LEE, CHIHYI NMN | 16d |
| 19441734 | BANDAGE WITH METAL LAYER | ALBERS, KEVIN S | — |
| 19261032 | TOPICAL SUNSCREEN | BECKHARDT, LYNDSEY MARIE | — |
| 19047284 | PRINT ON MASK AND PRINT ON CORE METHODS FOR 3D PRINTED CIRCUIT STRUCTURES | GATES, BRADFORD M | — |
| 18850815 | PEPTIDE HAVING ANTI-INFLAMMATORY AND ANTI-FIBROTIC ACTIVITIES AND USE THEREOF | BRADLEY, CHRISTINA | — |
| 18805330 | ANIMAL FEEDING APPARATUS | HUEBNER, ERICA MICHELLE | — |
| 18738723 | ELECTRONIC MODULE HAVING A PCB CAP STRUCTURE | SAWYER, STEVEN T | — |
| 18633291 | COMBINATION THERAPY FOR THE TREATMENT OF PSYCHIATRIC DISORDER | RAMOS LEWIS, JOSMALEN MILAGROS | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19067074 | COMBINATION THERAPY FOR THE TREATMENT OF PSYCHIATRIC DISORDER | RAMOS LEWIS, JOSMALEN MILAGROS | 34d |
| 19441734 | BANDAGE WITH METAL LAYER | ALBERS, KEVIN S | — |
| 19261032 | TOPICAL SUNSCREEN | BECKHARDT, LYNDSEY MARIE | — |
| 19047284 | PRINT ON MASK AND PRINT ON CORE METHODS FOR 3D PRINTED CIRCUIT STRUCTURES | GATES, BRADFORD M | — |
| 18911908 | ISOTOPOLOGUE MARKER FOR FLUID RESOURCES OR POLLUTANTS | HINES, LATOSHA D | — |
| 18850815 | PEPTIDE HAVING ANTI-INFLAMMATORY AND ANTI-FIBROTIC ACTIVITIES AND USE THEREOF | BRADLEY, CHRISTINA | — |
| 18805330 | ANIMAL FEEDING APPARATUS | HUEBNER, ERICA MICHELLE | — |
| 18753210 | ORAL QUETIAPINE SUSPENSION FORMULATIONS WITH EXTENDED SHELF LIFE AND ENHANCED BIOAVAILABILITY | AZPURU, CARLOS A | — |
| Art Unit | Apps |
|---|---|
| 1613 | 2 |
| 1628 | 2 |
| 3786 | 1 |
| 1621 | 1 |
| 1713 | 1 |
| 1771 | 1 |
| 3647 | 1 |
| 2847 | 1 |
| 4100 | 1 |
| 1655 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19441734 | BANDAGE WITH METAL LAYER | Lcp Medical Technologies, LLC | ALBERS, KEVIN S | 3786 | §102§103 | Non-Final OA | — | Pending | Jan 06, 2026 |
| 19261032 | TOPICAL SUNSCREEN | Concept Matrix Solutions | BECKHARDT, LYNDSEY MARIE | 1613 | §112DP | Non-Final OA | — | Pending | Jul 07, 2025 |
| 19067074 | COMBINATION THERAPY FOR THE TREATMENT OF PSYCHIATRIC DISORDER | Gskb Pharmaceuticals, LLC | RAMOS LEWIS, JOSMALEN MILAGROS | 1621 | §103 | Non-Final OA | 34d | Pending | Feb 28, 2025 |
| 19047284 | PRINT ON MASK AND PRINT ON CORE METHODS FOR 3D PRINTED CIRCUIT STRUCTURES | Lcp Medical Technologies, LLC | GATES, BRADFORD M | 1713 | §103§112 | Non-Final OA | — | Pending | Feb 06, 2025 |
| 18911908 | ISOTOPOLOGUE MARKER FOR FLUID RESOURCES OR POLLUTANTS | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | HINES, LATOSHA D | 1771 | §103 | Non-Final OA | — | Pending | Oct 10, 2024 |
| 18850815 | PEPTIDE HAVING ANTI-INFLAMMATORY AND ANTI-FIBROTIC ACTIVITIES AND USE THEREOF | Caregen Co., Ltd. | BRADLEY, CHRISTINA | §102§103 | Non-Final OA | — | Pending | Sep 25, 2024 | |
| 18846541 | A STABLE INJECTABLE COMPOSITION OF TRIAMCINOLONE ACETONIDE | Indoco Remedies Limited | CHI, AMANDA LYNN | §103 | Non-Final OA | — | Pending | Sep 12, 2024 | |
| 18805330 | ANIMAL FEEDING APPARATUS | Lafayette Bay Products LLC | HUEBNER, ERICA MICHELLE | 3647 | §102§103 | Final Rejection | — | Pending | Aug 14, 2024 |
| 18753210 | ORAL QUETIAPINE SUSPENSION FORMULATIONS WITH EXTENDED SHELF LIFE AND ENHANCED BIOAVAILABILITY | Tlc Therapeutics, LLC | AZPURU, CARLOS A | §112DP | Non-Final OA | — | Pending | Jun 25, 2024 | |
| 18738723 | ELECTRONIC MODULE HAVING A PCB CAP STRUCTURE | Dsbj Pte. Ltd. | SAWYER, STEVEN T | 2847 | §102§103 | Non-Final OA | — | Pending | Jun 10, 2024 |
| 18633291 | COMBINATION THERAPY FOR THE TREATMENT OF PSYCHIATRIC DISORDER | Gskb Pharmaceuticals, LLC | RAMOS LEWIS, JOSMALEN MILAGROS | 4100 | §103§112 | Non-Final OA | — | Pending | Apr 11, 2024 |
| 18631935 | SUSTAINED RELEASE STABLE EMULSION PHARMACEUTICAL FORMULATIONS | Insitu Biologics, Inc. | CORNET, JEAN P | 1628 | §103§112DP | Non-Final OA | — | Pending | Apr 10, 2024 |
| 18695739 | PEPTIDE HAVING ANTI-INFLAMMATORY ACTIVITY AND USE THEREOF | Caregen Co., Ltd. | HELLMAN, KRISTINA M | §102§112 | Non-Final OA | — | Pending | Mar 26, 2024 | |
| 18615846 | SUSTAINED RELEASE CANCER THERAPEUTICS FORMULATIONS | Insitu Biologics, Inc. | OLSON, ANDREA STEFFEL | §102§103 | Non-Final OA | — | Pending | Mar 25, 2024 | |
| 18683205 | EYE DAMAGE PREVENTION COMPOSITION CONTAINING DENDROPANAX MORBIFERA LEV. EXTRACT | Korea Ginseng Corp. | MI, QIUWEN | 1655 | §102 | Non-Final OA | — | Pending | Feb 12, 2024 |
| 18530154 | NEGATIVE HIGH VOLTAGE ELECTROSTATIC LUBRICANT FILTRATION MINIATURIZATION CONFIGURATION | Elf Holding Company LLC | WILKINS III, HARRY D | §102§103§112 | Non-Final OA | — | Pending | Dec 05, 2023 | |
| 18508992 | TRAZODONE ORAL SOLUTION | Owp Pharmaceuticals, Inc. | LEE, CHIHYI NMN | 1628 | §103§112 | Final Rejection | 16d | Pending | Nov 14, 2023 |
| 18247943 | A LIQUID INJECTABLE COMPOSITION OF DONEPEZIL | Pts Consulting, LLC | KENYON, JOHN S | 1625 | §112 | Non-Final OA | — | Pending | Apr 05, 2023 |
| 18176282 | AUTOMATIC DISTRIBUTION OF ACCESS CONTROL CREDENTIALS BASED ON A TASK | Livly, Inc. | SYED, NABIL H | 2689 | §103§112Other | Non-Final OA | — | Pending | Feb 28, 2023 |
| 17965738 | ECHOGENIC COMPOSITIONS AND METHODS OF USE THEREOF FOR THE TREATMENT OF PAIN | Insitu Biologics, Inc. | HOERNER, PAUL ELLSWORTH | 1611 | §103 | Final Rejection | 240d overdue | Pending | Oct 13, 2022 |
| 17758215 | ORAL DISSOLVABLE FILM AND METHOD OF MANUFACTURING AND USING THE SAME | Cure Pharmaceutical Holding Corp. | JANOSKO, CHASITY PAIGE | 1613 | §103 | Final Rejection | 168d overdue | Pending | Jun 29, 2022 |
| 17762727 | NUTRITIONAL COMPOSITION FOR VISUAL FUNCTION | Omniactive Health Technologies Limited | HIRAKIS, SOPHIA P | 1623 | §101§103 | Non-Final OA | — | Pending | Mar 22, 2022 |
| 16947005 | ORAL DISSOLVABLE FILM CONTAINING PSYCHEDELIC COMPOUND | Concept Matrix Solutions | PARK, HAEJIN S | 1614 | §103 | Non-Final OA | 5d | Pending | Jul 14, 2020 |
| 16946999 | TOPICAL COSMETIC | Concept Matrix Solutions | WRIGHT, SARAH C | 1619 | §103 | Non-Final OA | — | Pending | Jul 14, 2020 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial